Cheryl Erwin

1.6k total citations
20 papers, 865 citations indexed

About

Cheryl Erwin is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Cheryl Erwin has authored 20 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Cheryl Erwin's work include Genetic Neurodegenerative Diseases (8 papers), Epigenetics and DNA Methylation (5 papers) and BRCA gene mutations in cancer (4 papers). Cheryl Erwin is often cited by papers focused on Genetic Neurodegenerative Diseases (8 papers), Epigenetics and DNA Methylation (5 papers) and BRCA gene mutations in cancer (4 papers). Cheryl Erwin collaborates with scholars based in United States, Australia and Canada. Cheryl Erwin's co-authors include Jane S. Paulsen, Janet K. Williams, Christopher A. Ross, Deborah L. Harrington, Jeffrey D. Long, H. Jeremy Bockholt, Elizabeth Aylward, Ying Zhang, Holly James Westervelt and Hans J. Johnson and has published in prestigious journals such as The Lancet Neurology, Progress in Neurobiology and Genetics in Medicine.

In The Last Decade

Cheryl Erwin

19 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl Erwin United States 12 424 333 304 131 88 20 865
Roland Dominic G. Jamora Philippines 22 544 1.3× 209 0.6× 1.2k 4.1× 127 1.0× 61 0.7× 143 1.8k
Constance M. Bowe United States 21 417 1.0× 391 1.2× 233 0.8× 24 0.2× 156 1.8× 30 1.1k
Deepak Gupta United States 13 107 0.3× 140 0.4× 192 0.6× 33 0.3× 104 1.2× 33 607
Caroline Fertleman United Kingdom 9 215 0.5× 406 1.2× 67 0.2× 50 0.4× 59 0.7× 23 780
Raphael Machado Castilhos Brazil 14 207 0.5× 203 0.6× 135 0.4× 37 0.3× 41 0.5× 48 468
S Wiggins Canada 8 219 0.5× 141 0.4× 103 0.3× 150 1.1× 30 0.3× 10 442
Kimberly Korwek United States 15 291 0.7× 207 0.6× 75 0.2× 113 0.9× 15 0.2× 26 822
Eric Devine United States 16 121 0.3× 107 0.3× 61 0.2× 47 0.4× 74 0.8× 26 680
Sonia Khan Saudi Arabia 11 111 0.3× 136 0.4× 88 0.3× 118 0.9× 43 0.5× 30 626
Erynn S. Gordon United States 19 147 0.3× 352 1.1× 66 0.2× 510 3.9× 193 2.2× 39 1.0k

Countries citing papers authored by Cheryl Erwin

Since Specialization
Citations

This map shows the geographic impact of Cheryl Erwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Erwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Erwin more than expected).

Fields of papers citing papers by Cheryl Erwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Erwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Erwin. The network helps show where Cheryl Erwin may publish in the future.

Co-authorship network of co-authors of Cheryl Erwin

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Erwin. A scholar is included among the top collaborators of Cheryl Erwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Erwin. Cheryl Erwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dalpé, Gratien, Charles Dupras, Katherine Cheung, et al.. (2023). Defusing the legal and ethical minefield of epigenetic applications in the military, defense, and security context. Journal of Law and the Biosciences. 10(2). lsad034–lsad034. 3 indexed citations
2.
McGuire, Amy L., Mark P. Aulisio, F. Daniel Davis, et al.. (2020). Ethical Challenges Arising in the COVID-19 Pandemic: An Overview from the Association of Bioethics Program Directors (ABPD) Task Force. The American Journal of Bioethics. 20(7). 15–27. 84 indexed citations
3.
Philibert, Robert A. & Cheryl Erwin. (2015). A Review of Epigenetic Markers of Tobacco and Alcohol Consumption. Behavioral Sciences & the Law. 33(5). 675–690. 8 indexed citations
4.
Erwin, Cheryl. (2015). Ethical Issues Raised by Epigenetic Testing for Alcohol, Tobacco, and Cannabis. Behavioral Sciences & the Law. 33(5). 662–674. 7 indexed citations
5.
Erwin, Cheryl, et al.. (2015). Promoting the spiritual well-being of the healthcare team. Journal of Interprofessional Education & Practice. 1(2). 56–57.
6.
Paulsen, Jane S., Jeffrey D. Long, Hans J. Johnson, et al.. (2014). Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study. Frontiers in Aging Neuroscience. 6. 78–78. 161 indexed citations
7.
Paulsen, Jane S., Jeffrey D. Long, Christopher A. Ross, et al.. (2014). Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study. The Lancet Neurology. 13(12). 1193–1201. 180 indexed citations
8.
Erwin, Cheryl. (2014). Development of a Medical Humanities and Ethics Certificate Program in Texas. Journal of Medical Humanities. 35(4). 389–403. 8 indexed citations
9.
Philibert, Robert A., et al.. (2014). Methylation array data can simultaneously identify individuals and convey protected health information: an unrecognized ethical concern. Clinical Epigenetics. 6(1). 28–28. 37 indexed citations
10.
Philibert, Robert A., Sarah E. Shires, Tracy D. Gunter, et al.. (2014). A pilot examination of the genome-wide DNA methylation signatures of subjects entering and exiting short-term alcohol dependence treatment programs. Epigenetics. 9(9). 1212–1219. 65 indexed citations
11.
Goh, Anita, Edmond Chiu, Olga Yastrubetskaya, et al.. (2013). Perception, Experience, and Response to Genetic Discrimination in Huntington's Disease: The Australian Results of the International RESPOND-HD Study. Genetic Testing and Molecular Biomarkers. 17(2). 115–121. 18 indexed citations
12.
Paulsen, Jane S., Martha Nance, Noelle E. Carlozzi, et al.. (2013). A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases. Progress in Neurobiology. 110. 2–28. 114 indexed citations
13.
Erwin, Cheryl. (2012). Commentary on the Symposium on Social Justice and the Health Professions: Ethical and Experiential Issues. Pastoral Psychology. 62(2). 235–237. 1 indexed citations
14.
Williams, Janet K., Cheryl Erwin, Andrew R. Juhl, et al.. (2010). Personal Factors Associated with Reported Benefits of Huntington Disease Family History or Genetic Testing. Genetic Testing and Molecular Biomarkers. 14(5). 629–636. 21 indexed citations
15.
Williams, Janet K., Cheryl Erwin, Andrew R. Juhl, et al.. (2010). In their own words: Reports of stigma and genetic discrimination by people at risk for Huntington disease in the International RESPOND‐HD study. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 153B(6). 1150–1159. 41 indexed citations
16.
Erwin, Cheryl, Janet K. Williams, Andrew R. Juhl, et al.. (2010). Perception, experience, and response to genetic discrimination in Huntington disease: The international RESPOND‐HD study. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 153B(5). 1081–1093. 45 indexed citations
17.
Erwin, Cheryl. (2009). Behind the Genetic Information Nondiscrimination Act of 2008. AJN American Journal of Nursing. 109(12). 46–48. 4 indexed citations
18.
Erwin, Cheryl. (2008). Legal update: living with the Genetic Information Nondiscrimination Act. Genetics in Medicine. 10(12). 869–873. 20 indexed citations
19.
Penziner, Elizabeth, Janet K. Williams, Cheryl Erwin, et al.. (2007). Perceptions of discrimination among persons who have undergone predictive testing for Huntington's disease. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 147B(3). 320–325. 45 indexed citations
20.
Erwin, Cheryl & Steven M. Hersch. (2007). Monitoring reportable events and unanticipated problems: the PHAROS and PREDICT studies of Huntington disease.. PubMed. 29(3). 11–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roland Dominic G. Jamora Breakdown of academic impact, for papers by Constance M. Bowe Breakdown of academic impact, for papers by Deepak Gupta Breakdown of academic impact, for papers by Caroline Fertleman Breakdown of academic impact, for papers by Raphael Machado Castilhos Breakdown of academic impact, for papers by S Wiggins Breakdown of academic impact, for papers by Kimberly Korwek Breakdown of academic impact, for papers by Eric Devine Breakdown of academic impact, for papers by Sonia Khan Breakdown of academic impact, for papers by Erynn S. Gordon
Rankless by CCL
2026